Review of genetic testing in kidney disease patients: Diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2022-09 · 190 (3) · 358-376
DOI: 10.1002/ajmg.c.31995 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, online erschienen am 26.09.2022. Verfasst von Laura R Claus und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nierstichting.
Abstract (Originalsprache)
Genetic kidney disease comprises a diverse group of disorders. These can roughly be divided in the phenotype groups congenital anomalies of the kidney and urinary tract, ciliopathies, glomerulopathies, stone disorders, tubulointerstitial kidney disease, and tubulopathies. Many etiologies can lead to chronic kidney disease that can progress to end‐stage kidney disease. Despite each individual disease being rare, together these genetic disorders account for a large proportion of kidney disease cases. With the introduction of massively parallel sequencing, genetic testing has become more accessible, but a comprehensive analysis of the diagnostic yield is lacking. This review gives an overview of the diagnostic yield of genetic testing across and within the full range of kidney disease phenotypes through a systematic literature search that resulted in 115 included articles. Patient, test, and cohort characteristics that can influence the diagnostic yield are highlighted. Detection of copy number variations and their contribution to the diagnostic yield is described for all phenotype groups. Also, the impact of a genetic diagnosis for a patient and family members, which can be diagnostic, therapeutic, and prognostic, is shown through the included articles. This review will allow clinicians to estimate an a priori probability of finding a genetic cause for the kidney disease in their patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.
ORCID-Profile: Laura R Claus, Rozemarijn Snoek, Albertien M van Eerde
Förderung
- Nierstichting
Zitieren
APA
Claus, L. R., Snoek, R., Knoers, N. V. A. M., & van Eerde, A. M. (2022). Review of genetic testing in kidney disease patients: Diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 190(3), 358-376. https://doi.org/10.1002/ajmg.c.31995
Vancouver
Claus LR, Snoek R, Knoers NVAM, van Eerde AM. Review of genetic testing in kidney disease patients: Diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2022;190(3):358-376. doi:10.1002/ajmg.c.31995
BibTeX
@article{Claus2022,
author = {Claus, Laura R and Snoek, Rozemarijn and Knoers, Nine V A M and van Eerde, Albertien M},
title = {Review of genetic testing in kidney disease patients: Diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups},
journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
year = {2022},
volume = {190},
number = {3},
pages = {358--376},
doi = {10.1002/ajmg.c.31995}
}
EUVIMED